Lloyd’s Lab Central Fund invests in Axio and REOR20
Lloyd’s has confirmed that Axio and REOR20 will receive the first two investments from its Central Fund private markets allocation to support Lloyd’s Lab alumni.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below